Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global & Singapore Cancer Therapeutics Market to 2031
... one of the top causes of mortality in the country. As global cancer care evolves, Singapore has emerged as a prominent center for oncology drug development, attracting both domestic and international pharmaceutical companies to conduct ... Read More
-
Global & South Africa Cancer Therapeutics Market to 2031
... component of national expenditure. With both government and private sector investments increasing to enhance healthcare infrastructure, there is a growing demand for therapeutic solutions. As home to one of Africa’s most advanced healthcare systems, South ... Read More
-
Global & Slovakia Cancer Therapeutics Market to 2031
... alcohol consumption stands at 10 liters, exceeding the average across the European Union. Cancer screening rates are also below optimal levels; in 2023-2024, only about 25% of the eligible population underwent breast cancer screening, compared ... Read More
-
Global & United Arab Emirates Cancer Therapeutics Market to 2031
... In the federal budget for 2022, 8.4% of the government’s approved public spending—totaling US$15.8 billion (AED 58.931 billion)—was allocated to the healthcare sector. The UAE government remains the primary financier of its healthcare system and ... Read More
-
Global & United Kingdom Cancer Therapeutics Market to 2031
... by 2040.The emergence of immune checkpoint inhibitors has significantly transformed cancer treatment, offering renewed hope to patients. The UK also hosts Cancer Research UK, the world’s largest independent cancer charity. Each year, the organization allocates ... Read More
-
Global & Ukraine Cancer Therapeutics Market to 2031
... according to the World Health Organization. This figure is expected to rise in the coming years due to an aging population and the increasing prevalence of unhealthy lifestyle habits. As a result, there is a ... Read More
-
Global & United States Cancer Therapeutics Market to 2031
... reach around 2 million. Colorectal cancer ranks as the third most commonly diagnosed cancer among both men and women in the U.S., according to the American Society of Clinical Oncology. In 2023, about 150,000 adults ... Read More
-
Global & Austria Cancer Therapeutics Market to 2031
... around 50,000 annual cases by 2030. By that same year, the total number of individuals living with cancer in the country is projected to reach 460,000—an increase of 15% compared to 2022. The most frequently ... Read More
-
Global & Brazil Cancer Therapeutics Market to 2031
... of the population. This number is projected to increase to nearly 50 million by 2030, representing 24% of the total population. With a steadily aging population, Brazil is witnessing a surge in cancer incidence, particularly ... Read More
-
Global & Germany Cancer Therapeutics Market to 2031
... Organization (WHO) indicates that in 2022, Germany registered approximately 630,000 new cancer cases and around 250,000 cancer-related deaths. This growing burden is driving a strong demand for more effective treatment options. Germany is also recognized ... Read More
-
Global & Qatar Cancer Therapeutics Market to 2031
... The increasing number of cancer diagnoses has led to greater emphasis on advanced treatment options, including immunotherapy and targeted therapies. Healthcare is a priority for Qatar’s government under its National Vision 2030, which aims to ... Read More
-
Global & Sweden Cancer Therapeutics Market to 2031
... role in developing cutting-edge immuno-oncology therapies targeting cancers such as lung and bladder cancer. The Swedish government has taken proactive steps to strengthen its oncology sector through comprehensive national strategies. One such initiative, the Cancer ... Read More
-
Global & Taiwan Cancer Therapeutics Market to 2031
... in managing conditions such as non-small cell lung cancer (NSCLC), melanoma, and head and neck cancers. Additionally, the growing trend toward personalized therapies tailored to patients' genetic profiles has fueled demand for companion diagnostics and ... Read More
-
Global & India Cancer Therapeutics Market to 2031
... cancer, lung cancer, leukemia, and non-Hodgkin lymphoma are among the most frequently observed types. Specifically, breast cancer accounted for 13.5% (178,361) of all cancer cases and 10.6% (90,408) of cancer-related deaths, with a cumulative risk ... Read More
-
Global & China Cancer Therapeutics Market to 2031
... diagnoses and 3 million cancer-related deaths were reported in the country in 2020. Alarming statistics from WHO suggest that, on average, seven individuals are diagnosed with cancer every minute in China, and four die from ... Read More
-
Global & Italy Cancer Therapeutics Market to 2031
... cancer being the most frequently diagnosed, accounting for 13.2% of all cases. This was followed by colorectal cancer at 12.6% and lung cancer at 10.0%. That same year, cancer-related deaths reached around 190,000. Contributing to ... Read More
-
Global & Poland Cancer Therapeutics Market to 2031
... the Polish National Cancer Registry reported around 171,558 new cancer diagnoses and 93,652 cancer-related deaths. Additionally, data from the Spanish Network of Cancer Registries indicates that around 8,805 breast cancer deaths occurred in Poland that ... Read More
-
Global & Romania Cancer Therapeutics Market to 2031
... the Romanian Ministry of Health reporting approximately 100,000 new diagnoses each year. The increasing prevalence of risk factors such as tobacco use, unhealthy diets, and an aging population continues to drive cancer incidence rates, thereby ... Read More
-
Global & Philippines Cancer Therapeutics Market to 2031
... and the Philippine Health Insurance Corporation (PhilHealth), have significantly contributed to enhancing access to cancer care services and medications. Despite these advancements, challenges persist—particularly the high cost of therapies and limitations within the country’s healthcare ... Read More
-
Global Liquid Handling Systems Market - Focused Insights 2021-2030
... over 28%. By Method: The manual segment shows the highest growth of 8.75% during the forecast period. By Application: The drug discovery & development segment holds the largest market share. By End-User: In 2024, the ... Read More
-
Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2030
... largest share of the product category in 2024. Scanners are critical in enabling pathologists to view and analyze tissue samples on computer screens, as scanners convert physical glass slides to high-resolution digital images. The development ... Read More
-
Artificial Intelligence in Life Sciences Market Report by Offering (Software, Hardware, Services), Deployment (On-premises, Cloud-based), Application (Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision and Personalized Medicine, Patient Monitoring), and Region 2025-2033
... 21.5% during 2025-2033. The rising prevalence of complex diseases, the increasing adoption of AI in medical imaging analysis, the integration of AI into genomics research and analysis, and the convergence of AI with emerging technologies ... Read More
-
Uterine Cancer Therapeutics and Diagnostics
... Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Endometrial Carcinomas, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$19.0 Billion ... Read More
-
Dilated Cardiomyopathy Therapeutics
... at a CAGR of 4.3% over the analysis period 2024-2030. Angiotensin II Receptor Blockers (ARBs), one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$258.2 Million by ... Read More
-
Chlamydia Infection Diagnostics and Therapeutics
... Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 Billion by ... Read More
Research Assistance
